WKN: | 723808 |
ISIN: | DE0007238081 |
Region: | Deutschland |
Sektor: | Internet |
EQS-News: ABIVAX / Key word(s): Study results/Study Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative... ...weiterlesen